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Abstract
Aims: To characterize and explore the potential in extracellular biosynthesis of
silver nanoparticles (AgNPs) by Penicillium chrysogenum and Aspergillus oryzae
and to investigate the antifungal effect of chemically vs biologically synthesized
AgNPs comparing with conventional antifungal drugs against Trichophyton
rubrum.
Methods and Results: Chemically synthesized AgNPs (Chem-AgNPs) coated
with polyvinylpyrrolidone (PVP) were synthesized by chemical reduction
method with glucose in PVP aqueous solution. Biologically synthesized AgNPs
(Bio-AgNPs) were produced from the extracellular cell-free filtrate of
P. chrysogenum MUM 03.22 and A. oryzae MUM 97.19. Among the
commercial antifungal drugs, terbinafine exhibited the lower minimal
inhibitory concentration (MIC) range values of 0063–025 lg ml1 for the
clinical strains. Chem-AgNPs exhibited antifungal activity against all T. rubrum
strains. Bio-AgNPs produced by the fungal cell-free filtrate of P. chrysogenum
showed an antifungal activity higher than fluconazole but less than terbinafine,
itraconazole and Chem-AgNPs.
Conclusion: The synthesis parameters in future works should be carefully
studied to take full advantage of all the potential of filamentous fungi in the
synthesis of AgNPs.
Significance and Impact of the Study: Bio-AgNPs could be used as antifungal
agents, namely against dermatophytes.
Introduction
Fungi are a ubiquitous and diverse group of unique
organisms. Some groups of fungi are plant pathogens,
others can cause severe infections in human beings (Fer-
nandes et al. 2013; Pereira et al. 2014). Emerging and re-
emerging fungal pathogens have been continuously
detected and described (Dias et al. 2011a; Santos et al.
2011). Among humans, the dermatophytoses, which are
skin diseases caused by a group of fungi called dermato-
phytes, have the highest incidence worldwide with an
estimation of 20–25% of the population infected (Hav-
lickova et al. 2008; Dias et al. 2011b). Although the con-
dition is relatively benign and easy to treat, infections
caused by dermatophytes are often associated with
relapses after antifungal therapy (Gupta and Cooper
2008; Mukherjee et al. 2008; Dias et al. 2011b). More-
over, dermatophytoses can cause major problems in
immunocompromised hosts (Garber 2001; Nir-Paz et al.
2003), and some studies have also shown an increasing
prevalence of fungal skin infections in patients infected
with HIV (Mirmirani et al. 2001; Freytes et al. 2007).
Besides the concern about this upward trend, it is
believed that prophylaxis with antifungals may lead to
the emergence of resistant strains (Mukherjee et al.
2003). Therefore, there is a pressing need to search for a
new generation of antifungal agents (Kim et al. 2007;
Auberger et al. 2012).
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Among inorganic antimicrobial agents, silver has been
employed most widely since ancient times to fight infec-
tions. The antibacterial and antiviral activities of silver,
silver ions and silver compounds have been thoroughly
investigated (Singh et al. 2008). Silver is a metal widely
used in the pharmaceutical formulations for their anti-
septic properties. It has been described that the small size
of the silver particles enhances the antimicrobial proper-
ties (Toshijazu 1999). Increasing the ratio between the
surface area and the volume up to the nanoscale, the
antimicrobial effect is amplified; that is, more sites of
interaction with biological receptors are available (Lee
et al. 2003), providing a strong contact with micro-
organisms surface, thus increasing their antimicrobial effi-
ciency (Rai et al. 2009; Thakkar et al. 2010; Reidy et al.
2013).
Although well-known toxic effects of silver in micro-
organisms (Sondi and Salopek-Sondi 2004), the mecha-
nisms by which it exerts its bioactivity are still not very
well understood or agreed upon (Marambio-Jones and
Hoek 2010; Reidy et al. 2013). Some studies have
reviewed this point in detail attributing the antimicrobial
activity of silver to three common mechanisms, namely
(i) uptake of free silver ions followed by disruption of
ATP production and DNA replication; (ii) generation of
reactive oxygen species (ROS) by silver nanoparticles (Ag-
NPs) and silver ion; and (iii) direct disruption of cell
membrane integrity by the formation of ‘pits’ on the
membrane surface leading to cell death (Marambio-Jones
and Hoek 2010; Reidy et al. 2013).
Different sizes and shapes of AgNPs can be easily syn-
thesized by conventional chemical methods (Tran et al.
2013), where most of them can present high environmen-
tal impact, however. Generally, chemical methods are
inexpensive to produce AgNPs on large scale. Neverthe-
less, most synthetic methods rely heavily on the use of
toxic organic solvents and reducing agents (Pastoriza-
Santos and Liz-Marzan 2009). All these chemicals are
highly reactive and can induce potential environmental
and biological contamination (Xu et al. 2003; Sui et al.
2008). To develop a synthesis process of metal nanoparti-
cles more eco-friendly, the use of natural sources, such as
biological systems, becomes essential. A vast array of
microbial resources available in nature can be employed
as an alternative to the use of hazardous chemicals for
AgNPs synthesis (Thakkar et al. 2010).
Different micro-organisms have different mechanisms
of producing nanoparticles (Li et al. 2011). However, in
the biological approach, it has been suggested that bio-
molecules, secreted in large amounts by micro-organisms,
are involved in the reduction of metal ions, thus control-
ling the size of the nanoparticles (Kumar et al. 2007;
Thakkar et al. 2010). There are some advantages of
biological over chemical synthesis of nanoparticles. The
manipulation of microbial cultures is easy, and the actual
refining process of the biomass is simpler in comparison
with synthetic methods (Ingle et al. 2008). Biosynthetic
nanoparticles have a lower environmental impact because
their synthesis does not require any toxic chemical, and
also, the synthesis process occurs at ambient temperature
and ambient pressure conditions (Gade et al. 2008; Muk-
herjee et al. 2008). The use of fungi is potentially inter-
esting because they exhibit tolerance and metal
bioaccumulation potential and secrete large amounts of
enzymes and the scale-up synthesis of nanoparticles to a
larger scale is easier (Rai et al. 2011). Consequently, bio-
logical approach has shown to be cost-effective, simpler
and focus towards a greener approach (Maliszewska
2011).
Several studies have reported potent antifungal activity
of AgNPs against pathogenic fungi, and most of them
have been focused on the effect of AgNPs on the Candida
species (Chwalibog et al. 2010; Monteiro et al. 2011; Nas-
rollahi et al. 2011; Hwang et al. 2012; Rajarathinam and
Kalaichelvan 2013). However, only few studies have been
performed to assess the effects of AgNPs on dermato-
phytes. The antifungal activity of AgNPs in biostabilized
footwear materials was evaluated against dermatophytes
and other fungi (Falkiewicz-Dulik and Macura 2008).
Chemically synthesized AgNPs (Chem-AgNPs) shown
antifungal activity against clinical isolates of Trichophyton
mentagrophytes (Kim et al. 2008). Noorbakhsh (2011)
investigated the effects of biologically synthesized AgNPs
(Bio-AgNPs) by Klebsiella pneumoniae against Trichophy-
ton rubrum. In addition, Marcato et al. (2012) have also
reported the significant antifungal activity of Bio-AgNPs
against T. rubrum by the disc diffusion test.
The main aims of this study were (i) to explore the
potential in extracellular biosynthesis of Bio-AgNPs by
different filamentous fungi, (ii) characterize the obtained
Bio-AgNPs and chemically synthesized AgNPs (Chem-Ag-
NPs), (iii) evaluate the antifungal effect of Chem-AgNPs
vs Bio-AgNPs and (iv) compare the performance of both
AgNPs with conventional antifungal drugs.
Materials and methods
Fungal strains
In this work, the fungi Penicillium chrysogenum MUM
03.22, Aspergillus oryzae MUM 97.19 and eight clinical
strains of T. rubrum MUM 08.05; 08.09; 08.10; 08.11;
08.12; 09.18; 10.128 and 10.133 were obtained from the
Portuguese fungal culture collection Micoteca da Univer-
sidade do Minho (MUM, Braga, Portugal). The reference
strain T. rubrum ATCC MYA-4438 was obtained from
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the American Type Culture Collection (ATCC—LGC
Standards S.L.U., Barcelona, Spain).
Chem-AgNPs
Chem-AgNPs coated with polyvinylpyrrolidone (PVP)
were synthesized with some modifications by chemical
reduction method with glucose in PVP aqueous solution
as described elsewhere (Wang et al. 2005). Briefly, 2 g of
glucose (Fluka: Buchs, Switzerland) and 1 g PVP
10 000 g mol1 (Sigma-Aldrich: St. Louis, MO, USA)
were dissolved into 40 ml of Milli-Q deionized water
(solution A). The silver aqueous solution was prepared
by dissolving 05 g of AgNO3 (Sigma: Sigma-Aldrich, St.
Louis, MO, USA) in 1 ml of Milli-Q deionized water
(solution B). Solution A was heated to 70°C under con-
tinuous stirring. When thermometer registered 70°C,
solution B was then added dropwise to solution A with a
flow rate 1 drop/s and continuous stirring. The disper-
sion was maintained at 70°C for 1 h and then cooled to
room temperature. The particles were separated from oxi-
dation products, glucose, PVP, AgNO3
 and Ag+ by cen-
trifugation (5000 g, 5 min).
Bio-AgNPs
For the biosynthesis of AgNPs, the methodologies pre-
sented by Ahmad et al. (2003) and Duran et al. (2005)
were taken into consideration. However, some modifica-
tions were put in place, as follows. Fungal cells were
grown in glucose-yeast extract-peptone (MGYP) liquid
medium (03% malt extract, 1% glucose, 03% yeast
extract and 05% peptone) and incubated at 30°C with
150 rev min1 for 72 h. The fungal biomass was then
harvested followed by extensive washing with Milli-Q de-
ionized water. In a glass flask, 10 g (wet weight of bio-
mass) was added to 100 ml of Milli-Q deionized water
and incubated with shaking for 72 h (30°C at
150 rev min1). Afterwards, the fungal biomass in the
aqueous suspension was filtered through a Whatman
grade 1 filter paper (Whatman: Buckinghamshire, UK),
and the fungal filtrate was finally obtained.
Biosynthesis of Bio-AgNPs was achieved by adding
1 mmol l1 AgNO3 to 100 ml of the fungal filtrate,
which was incubated in the dark at 30°C and
150 rev min1 for 96 h. Control flask, without the
AgNO3, was incubated at same conditions. Aliquots of
the reaction solution were taken at 96 h of incubation for
characterization of Bio-AgNPs by Ultraviolet-Visible
(UV/VIS) spectrophotometer analysis and dynamic light
scattering (DLS). The remaining aqueous solution con-
taining Bio-AgNPs (reaction solution) was purified by
repeated centrifugation at 5000 g for 15 min followed by
redispersion of the pellet of Ag-NPs in Milli-Q deionized
water. After freeze-drying, the samples were ready for fur-
ther analysis by X-ray diffraction (XRD), Fourier trans-
form infrared (FT-IR) and scanning electron microscopy
(SEM/EDS).
Ultraviolet-Visible Spectroscopy
The detection of silver nanoparticles was performed by
UV/VIS spectrophotometer (V-560 Jasco: Tokyo, Japan)
equipped with a double-beam system and double mono-
chromator, in a wavelength ranging 200–800 nm at a res-
olution of 1 nm, for each sample.
Dynamic light scattering
The size distribution and the polydispersity of the AgNPs
were studied by DLS technique. A sample of 1 ml of the
reaction solution was placed in disposable plastic
cuvettes, and the hydrodynamic diameter of the AgNPs
was measured in the Malvern Instrument Zetasizer Nano
ZS (Malvern, UK). Measurements were taken at 25°C in
triplicate.
Scanning electron microscopy
Morphological characterization and elemental analysis of
Bio-AgNPs were performed with an ultrahigh-resolution
field emission scanning electron microscope (NanoSEM
—FEI Nova 200—FEG/SEM: OR, USA), with integrated
microanalysis X-ray system (energy dispersive spectrome-
ter (EDS)) and electron backscatter diffraction (EBSD,
EDAX—Pegasus X4M (EDS/EBSD)). For SEM analysis, a
portion of freeze-dried of each Chem-AgNPs and Bio-Ag-
NPs was loaded in the specimen holder of the equipment
and afterwards analysed.
X-ray diffraction
The structure and composition of freeze-dried Chem-Ag-
NPs and Bio-AgNPs were analysed by XRD equipment
(Bruker D8 Discover: Karlsruhe, Germany) operated at a
voltage of 40 kV adjustable in steps of 1 kv with a h- 2 h
configuration and Cu Ka radiation (k = 15406 A). The
diffracted intensities were recorded from 30° to 80° 2h
angles.
FT-IR analysis
The interaction between polymeric structure of PVP with
Chem-AgNPs and proteins with Bio-AgNPs in freeze-
dried samples was analysed by FT-IR using a Bruker IFS
66V equipment (Bruker) in a wavelength ranging from
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4000 to 500 cm1. For comparison purpose, FT-IR spec-
trum of pure PVP 10 000 g mol1 was obtained from
the open Japanese database ‘Spectral Database for
Organic Compounds, SDBS’, a free database of the
National Institute of Advanced Industrial Science and
Technology (AIST), Japan (http://sdbs.db.aist.go.jp/sdbs/
cgi-bin/cre_index.cgi—date of access: 09 June 2014).
Susceptibility tests to antifungal agents
Antifungal drugs
Commercial antifungal terbinafine hydrochloride (>98%;
Sigma-Aldrich), itraconazole (>98%, TLC; Sigma-Aldrich)
and fluconazole (>98%, HPLC; Sigma-Aldrich) were used
as reference drugs. A stock solution of antifungal drugs
was prepared at concentrations 100 times the highest
concentration tested for each antifungal drug. Terbinafine
and itraconazole were dissolved in DMSO, and fluconaz-
ole was dissolved in distilled water. Aliquots were pre-
pared and stored at 80°C. The concentration ranges
used were 00078–4 lg ml1 for terbinafine, 00313–
16 lg ml1 for itraconazole and 0125–64 lg ml1 for
fluconazole. Final concentration of DMSO never exceeded
1% of the final concentration of drugs, even in the con-
trol (without antifungal drug).
Concentration of AgNPs
For susceptibility test, freeze-dried of Chem- and Bio-Ag-
NPs was dispersed by ultra-sonication in Milli-Q deion-
ized water to produce a stock solution with the final
concentration of 20 lg mol1. Then, the stock solution
was diluted in RPMI-1640 medium (with glutamine,
without bicarbonate and with phenol red as pH indica-
tor) buffered to pH 70  01 at 25°C, supplemented
with 10% foetal bovine serum (FBS) (Invitrogen: Carls-
bad, CA, USA) to produce work solutions with the fol-
lowing concentrations: 025, 05, 10, 20, 25, 30, 35,
40, 50 and 75 lg ml1.
Susceptibility test procedure
Clinical and ATCC MYA-4438 strains of T. rubrum were
grown at 30°C for 7–10 days in potato dextrose agar
slants (PDA; Oxoid, UK). The procedure followed the
Clinical and Laboratory Standards Institute document
M38-A2 (CLSI 2008).
A serial concentration of each antifungal drugs and Ag-
NPs was used in the range described above. The inocu-
lum size was set in a range of 04 9 104 to
5 9 104 CFU ml1. The microdilution plates inoculated
with 100 ll of fungal conidia were incubated at 30°C,
and the turbidity of the growth control wells was
observed every 48 h. The minimal inhibitory concentra-
tion (MIC) of each strain was defined as the lowest con-
centration that inhibited 80% of the fungal growth and
was determined by a comparison with the fungal growth
in the control well.
Results
Characterization of Chem-AgNPs and Bio-AgNPs
During reduction reaction, the reaction solution of
Chem-AgNPs changed from translucent white to dark
brown. For Bio-AgNPs, the reaction solution changed
from pale yellow to dark brown. No changing of colour
was observed neither in the control flasks, containing
only Milli-Q deionized water supplemented with
1 mmol l1 AgNO3, nor in the fungal filtrate without
AgNO3 (data not shown).
The reduction reaction of the silver ion (Ag+) to the
silver metal (Ag0) was monitored by UV/VIS spectropho-
tometry. A unique spectral response was displayed at
430 nm for Chem-AgNPs (data not shown). In Fig. 1,
the UV/VIS spectrum of Bio-AgNPs produced by
P. chrysogenum MUM 03.22 showed a single peak at
430 nm, but a wide band in the range between 400 and
550 nm was observed for Bio-AgNPs produced by A. ory-
zae MUM 97.19. No absorption band was observed on
the spectra of blank solution.
The physicochemical properties such as size distribu-
tion and polydispersity index were analysed by DLS
(Table 1). The size distribution of Chem-AgNPs was
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Figure 1 UV/VIS spectrum after 96 h of AgNO3 reduction by reaction
solution of Penicillium chrysogenum MUM 97.19 (black line) and
Aspergillus oryzae MUM 03.22 (grey line). Blank represents the cell-
free filtrate without AgNO3 (dashed line).
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found to be monomodal, with average particle size of
7372 nm and polydispersity of 0254. In contrast, a
bimodal size distribution was found for Bio-AgNPs pro-
duced by P. chrysogenum MUM 03.22 with average parti-
cle size of 1006 nm. A polydispersity index of 0230 was
also observed for these nanoparticles. Bio-AgNPs pro-
duced by A. oryzae MUM 97.19 showed a bimodal size
distribution with average particle size of 7614 nm and a
polydispersity index of 0377.
Each Chem-AgNPs and Bio-AgNPs obtained were also
characterized by SEM analysis (Fig. 2). The representative
SEM micrograph recorded from a drop-coated film of
Chem-AgNPs deposited on a carbon-coated copper grid
is displayed in Fig. 2a. Variable shapes (spherical to poly-
hedric particles) formed with size ranging from 25 to
75 nm were observed. The average particle size diameter
of spherical Chem-AgNPs was 52 nm although some
aggregates were also present. In contrast, micrographs
taken from Bio-AgNPs synthesized by P. chrysogenum
MUM 03.22 and by A. oryzae MUM 97.19 (Fig. 2b,c,
respectively) showed mostly spherical-shaped nanoparti-
cles formed with diameters ranging from 19 to 60 nm.
To provide confirmation on the presence of silver ions in
the solution, analysis on SEM-EDS was recorded (Fig. 3).
A peak of metallic copper that was found for Chem-
AgNPs (Fig. 3a) was generated from the carbon-coated
copper grid and did not account for the final analysis.
The EDS optical absorption peak was observed approxi-
mately at 3 keV, indicating the presence of AgNPs in the
reaction solution of P. chrysogenum MUM 03.22 and
A. oryzae MUM 97.19, respectively (Fig. 3b,c).
FT-IR spectroscopy is a suitable and sensitive method
to characterize and detect the interaction between two
chemical species. The FT-IR spectra for Chem-AgNPs
and Bio-AgNPs are displayed in Fig. 4a–c. The infrared
spectra of both pure e and PVP-capped AgNPs are quite
different. The C=O groups of pure PVP show a promi-
nent band at 1663 cm1 in the infrared spectrum (data
not shown). This characteristic band can be subjected to
a shift when an interaction between PVP and metal spe-
Table 1 Physicochemical parameters of size distribution and polydi-
spersion value for Chem-AgNPs, and Bio-AgNps produced by Penicilli-
um chrysogenum MUM 03.22 and Aspergillus oryzae MUM 97.19
cell-free filtrate
Z—average
size (nm) Polydispersion Distribution
Chem-AgNPs 7372 0254 Unimodal
Bio-AgNPs
P. chrysogenum
MUM 03.22
1006 0230 Bimodal
Bio-AgNPs A. oryzae
MUM 97.19
7614 0377 Bimodal
(a)
(b)
(c)
Figure 2 Representative scanning electron microscopy (SEM) micro-
graph of (a) Chem-AgNPs, (b) Bio-AgNPs synthesized by Penicillium
chrysogenum MUM 97.19 and (c) Bio-AgNPs synthesized by Aspergil-
lus oryzae MUM 03.22.
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Figure 3 Energy dispersive spectrometer
(EDS) spectrum of (a) Chem-AgNPs, (b) Bio-
AgNPs synthesized by Penicillium
chrysogenum MUM 97.19 and (c) Bio-AgNPs
synthesized by Aspergillus oryzae MUM
03.22.
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cies occur (Tu 2008). In this study, this shift was
observed for the C=O group of PVP-capped Chem-
AgNPs. In this case, a band at 1646 cm1 was observed
(Fig. 4a). The band shifts reveal that there exists an inter-
action between metal precursors and PVP.
The infrared spectra of both Bio-AgNPs produced by
P. chrysogenum MUM 03.22 and A. orizae MUM 97.19
presented bands seen at 3220 cm1 with a shoulder at
3090 cm1, which were assigned to the stretching vibra-
tions of primary and secondary amines, respectively
(Fig. 4b,c). Their corresponding bending vibrations were
seen at 1640 and 1530 cm1, respectively. The two bands
observed at 1370 and 1033 cm1 can be assigned to the
C–N stretching vibrations of aromatic and aliphatic
amines, respectively. Based on the infrared data, overall
observation confirms the presence of protein in the sam-
ples of both Bio-AgNPs. It was reported earlier that pro-
teins can bind to nanoparticles either through free amine
groups or cysteine residues in the proteins (Vigneshwaran
et al. 2007).
The crystalline structure of Bio-AgNPs synthesized
P. chrysogenum MUM 03.22 was confirmed by the XRD
pattern corresponding to the (111), (200), (220) and (311)
planes at 2h angles of 3808°, 4428°, 6448° and 7748°,
respectively (Fig. 5). The obtained XRD pattern was in
good agreement with the unit cell of the face-centred cubic
(fcc) structure of synthetic silver (ICSD File No. 01-089-
3722) with a lattice parameter of a = 40855 A. Other dif-
fraction peaks were also observed at 2h angles of 3208°,
4600°, 546° and 573° in the XRD profile. This might be
related to silver chloride and silver oxide involved during
the preparation of the cell-free filtrate.
Susceptibility tests
In this study, antifungal susceptibility of the eight clinical
strains of T. rubrum and the reference strain T. rubrum
ATCC MYA-4438 were tested against three commercial
antifungal drugs (terbinafine, itraconazole and fluconaz-
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Figure 4 Fourier transform infrared (FT-IR) spectrum of (a) Chem-
AgNPs, (b) Bio-AgNPs synthesized by Penicillium chrysogenum MUM
97.19 and (c) Bio-AgNPs synthesized by Aspergillus oryzaeMUM03.22.
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Figure 5 Example of representative X-ray diffraction pattern of
freeze-dried silver nanoparticles synthesized by the reduction of silver
nitrate with Penicillium chrysogenum MUM 97.19 cell-free filtrate
(a.u. = arbitrary units).
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ole), and Chem-AgNPs and Bio-AgNPs produced by
P. chrysogenum MUM 03.22 and A. oryzae MUM 97.19.
To determine the MIC, the plates were evaluated after
5 days of incubation (Table 2). The reference strain
T. rubrum ATCC MYA-4438 was the most susceptible
fungus against itraconazole, fluconazole, Chem-AgNPs
and Bio-AgNPs. In contrast, it was the less susceptible to
terbinafine. Among the commercial antifungal drugs eval-
uated, terbinafine exhibited the lower MICs values
(0063–025 lg ml1) for all clinical strains.
Chem-AgNPs showed antifungal activity in the range
from 025 to 25 lg ml1. Furthermore, Chem-AgNPs
exhibited a stronger inhibitory effect against all T. rubrum
strains evaluated, which MIC values were at least twofold
higher than the MIC values of Bio-AgNPs (data not shown).
Bio-AgNPs produced by P. chrysogenum MUM 03.22
showed an antifungal activity in the range from 05 to
50 lg ml1. The Bio-AgNPs produced by that fungi
exhibited higher antifungal activity than fluconazole, but
lower activity than terbinafine, itraconazole and Chem-
AgNPs. In contrast, Bio-AgNPs produced by A. oryzae
MUM 97.19 did not exhibit antifungal activity in concen-
trations up to 75 lg ml1. Regardless of the process
used, Chem-AgNPs and Bio-AgNPs produced by P. chrys-
ogenum MUM 03.22 (geometric mean of MIC val-
ues = 119 and 289 lg ml1, respectively) exhibited a
stronger inhibiting activity than fluconazole (geometric
mean of MIC values = 565 lg ml1).
Discussion and conclusion
Nanoparticle biosynthesis using filamentous fungi has
recently emerged as a simple and viable alternative to
those procedures involving the physicochemical synthetic
route (Hemath et al. 2010). In the present study, the
synthesis and antifungal activity of both Chem-AgNPs
and Bio-AgNPs were assessed. Chem-AgNPs were colloi-
dally stabilized by the polymer PVP (10 000 g mol1).
The UV/VIS spectrum for this sample resulted in a maxi-
mum absorption band at 430 nm, which was in accor-
dance with previous studies (Kittler et al. 2010; Racles
et al. 2010). The Chem-AgNPs were stable after
3 months, once no precipitation was observed and the
solution containing it was evaluated by UV/VIS and no
changing was registered over the time (data not shown).
The fungal strains P. chrysogenum MUM 03.22 and
A. oryzae MUM 97.19 were used as biological models for
the extracellular biosynthesis of stable Bio-AgNPs. After
silver nitrate addition to the fungal cell-free filtrate, the
colour of the reaction solution changed over the time of
incubation, which indicated the formation of Bio-AgNPs.
According to previous published data, the changing in
the reaction solution colour is due to the excitation of
surface plasmon vibrations in the Bio-AgNPs (Mulvaney
1996; Elechiguerra et al. 2005). Furthermore, the absor-
bance band between 380 and 420 nm indicates the for-
mation of spherical or roughly spherical Bio-AgNPs
(Hasell et al. 2007; Pal et al. 2007).
Differences were found between UV/VIS spectra of
Bio-AgNPs. For nanoparticles produced by P. chrysoge-
num MUM 03.22, a plasmon resonance band at 420 nm
was obtained. The wide band observed on the spectrum
of Bio-AgNPs produced by A. oryzae MUM 97.19 indi-
cated a heterogeneous suspension. An absorption band at
270 nm was also found on both Bio-AgNPs spectra. This
band is attributed to the electronic excitation of both
aromatic tyrosine and tryptophane residues in proteins
(Lakowicz 2006). It indicates the presence of extracellu-
Table 2 Minimum inhibitory concentrations (MICs) of antifungal commercial drugs, Chem- and Bio-AgNPs on clinical and reference strain of
Trichophyton rubrum
Species (Number of isolates) Antifungal agents
MIC (lg ml1)
Range Geometric mean
T. rubrum Clinical strains (8) Terbinafine 0063–025 014
Itraconazole 0063–1 018
Fluconazole 1–32 565
Chem-AgNPs 05–25 119
Bio-AgNPs (Penicillium chrysogenum MUM 03.22) 05–5 289
Bio-AgNPs (Aspergillus oryzae MUM 97.19) >75 >75
T. rubrum ATCC MYA 4438 Terbinafine 4 nd
Itraconazole 0063–0126 nd
Fluconazole 05–16 nd
Chem-AgNPs <025 nd
Bio-AgNPs (P. chrysogenum MUM 03.22) 05 nd
Bio-AgNPs (A. oryzae MUM 97.19) >75 nd
nd, not determined.
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lar proteins in the filtrate solution and the possible
involvement of the amino acids in the reduction and sta-
bility of metallic ions (Mandal et al. 2006). The presence
of proteins in Bio-AgNPs was confirmed by the FT-IR
analyses. FT-IR measurements of the freeze-dried samples
were taken to identify the possible interactions between
silver and bioactive molecules, which may be responsible
for stabilization of AgNPs. The amide linkages between
amino acid residues in proteins lead to well-known signa-
tures in the infrared region of the electromagnetic spec-
trum. FT-IR spectrum reveals two bands at 3207 and
3065 cm1 that corresponds to stretching vibrations of
the amide primary and secondary bands of the proteins,
respectively. The presence of the signature peaks of
amino acids supports the presence of proteins in fungal
cell-free filtrate as observed in UV/VIS spectra.
The SEM micrographs show the high density of nano-
structures, confirming the presence of Chem-AgNPs and
Bio-AgNPs. Differences in the average size of Chem-AgNPs
and Bio-AgNPs were found comparing DLS and SEM
analyses. Results from DLS suggested an average size of
almost twofold for Bio-AgNPs than Chem-AgNPs. In fact,
DLS technique measures the hydrodynamic diameter of
the particle. It gives the information of the inorganic core
along with any coating material and the solvation layer
attached to the particle. It means that nanomaterial sizing
determined by techniques that use wet dispersion is com-
monly overestimated (De Palma et al. 2007; Dhawan and
Sharma 2010). In contrast, SEM analysis uses dehydrated
samples, where only the inorganic core and the coating
material were taken into account. In addition, due to poor
contrast, the measurement of the coating layer can some-
times be underestimated (Gaumet et al. 2008).
A thick cap surrounding the nanoparticles could be
observed in SEM micrographs. This is probably due to
the biomolecules released from the fungus (Duran et al.
2005) acting as stabilizing agents of the nanoparticles.
The absorption peak on SEM-EDS was observed at
approximately 3 keV, which is characteristic of silver
nanocrystals. The presence of other peaks besides silver
products in the EDS spectra indicated the heterogeneity
of the reaction solution.
The development of a protocol to synthesize AgNPs
with controlled size and shape is critical (Birla et al.
2013). In fact, it has been reported that the shape of Ag-
NPs may interfere with their antimicrobial effect (Pal
et al. 2007). Recent studies have confirmed that metal
nanomaterial has good antimicrobial activity and among
inorganic agents, silver has been most widely employed
since ancient times (Jung et al. 2008).
The biological activity of Chem-AgNPs and Bio-AgNPs
was evaluated against eight clinical strains of T. rubrum
and reference strain T. rubrum ATCC MYA-4438. The
differences between the MIC values of Chem-AgNPs and
Bio-AgNPs produced by P. chrysogenum MUM 03.22 can
be in part explained by the size ranges of the nanoparti-
cle, as the smaller sized Chem-AgNPs exhibited lower
MIC range than Bio-AgNPs. Previous studies indicated
that size and shape of AgNPs have a direct implication
on potential toxicity (Singh et al. 2008; De Lima et al.
2012). Therefore, the presence of uncapped Ag0 nanopar-
ticles in the Chem-AgNPs suspension could exhibit per se
high toxicity (Pal et al. 2007; Kvitek et al. 2009; Kittler
et al. 2010). However, AgNPs with smaller sizes have a
higher antimicrobial activity, as smaller particles with a
larger surface-to-volume ratio provide a more efficient
means of antimicrobial activity (Baker et al. 2005;
Panacek et al. 2009; Duran et al. 2010).
Reduced antifungal activity against clinical and reference
T. rubrum strains of the reaction solution of A. oryzae
MUM 97.19 could be associated with the coating of the
nanoparticles, and the results suggested that the biomole-
cules coating the AgNPs might play an important role in
the antimicrobial effect. Our results suggested that AgNPs
capping might also be involved in the antifungal activity,
because Chem-AgNPs which was only covered with PVP
exhibited higher biological activity against T. rubrum
strains than the biological capping of AgNPs produced by
fungi. Irrespective of the process used, Chem- and Bio-Ag-
NPs exhibited at least tenfold stronger inhibiting activity
against dermatophytes than fluconazole. This result is in
accordance with Kim et al. (2008), who reported that Ag-
NPs shown higher activity than fluconazole towards all
fungal strains tested, including T. mentagrophytes.
For susceptibility tests involving AgNPs, the stabilization
of AgNPs in the culture medium is required, besides the
agglomeration of AgNPs can greatly compromise their anti-
microbial activity (Lok et al. 2007). So it is recommended
performing agglomeration tests to understand and monitor
the stabilization of AgNPs in culture medium (Kittler et al.
2010). In our study, the presence of salts in the RPMI med-
ium interfered with the stabilization of the Chem-AgNPs
leading to their agglomeration (data not shown). The PVP
capping of the Chem-AgNPs was undertaken to enable a
more effective redispersion and reduced propensity towards
aggregations by steric hindrance (Kvitek et al. 2008). It is
known that capping agents increase the solubility of the
nanosystem, being also used as a site for bioconjugation of
the nanoparticle with important molecules (Sing et al.
2009; Seabra and Duran 2010). The PVP capping of Chem-
AgNPs was confirmed by FT-IR analysis comparing IR spec-
tra of pure PVP 10 000 g mol1 and PVP-capped Chem-
AgNPs. The characteristic band of the C=O groups at
1663 cm1 (pure PVP) can be subjected to a shift when an
interaction between PVP and metal species occur (Tu
2008). In the present study, a band at 1646 cm1 was
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observed for Chem-AgNPs capped with PVP. The band
shifts reveal an interaction between metal precursors and
PVP. Based on the IR data, overall observation confirms the
presence of protein in the samples of both Bio-
AgNPs. It was reported earlier that proteins can bind to
nanoparticles through either free amine groups or cysteine
residues in the proteins (Vigneshwaran et al. 2007).
The antifungal drug terbinafine has shown higher anti-
fungal activity than all Chem- and Bio-AgNPs; neverthe-
less, the terbinafine-resistant strain ATCC MYA-4438 was
susceptible to nanoparticles exposition, which antifungal
mechanism of action is different than the commercial
drug. It is known that conventional antifugal treatments
have limitations associated with their toxicity, antifungal
resistance, relapses and high treatment costs (Khan et al.
2010). The presence of clinical isolates of terbinafine-
resistant T. rubrum exhibiting high-level primary
resistance to terbinafine, which is one of the most used
antifungal drugs (Mukherjee et al. 2003; Favre et al.
2004), reinforces the issue that resistance to antifungal
drugs represents an important impact in the management
of fungal diseases. Notwithstanding the reduced antifun-
gal activity of the strain A. oryzae MUM 97.19, promising
results were found for the Bio-AgNPs produced from the
cell-free filtrate of P. chrysogenum MUM 03.22.
The synthesis parameters in future studies should be
carefully studied to take full advantage of all the potential
of filamentous fungi in the synthesis of Bio-AgNPs, which
revealed as potential antifungal agent, that could help to
prevent superficial cutaneous fungal infections.
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